NEW YORK (AP) — Alimera Sciences and pSivida said Friday the FDA approved their eye disease implant Iluvien.
Iluvien is an implant delivered by injection that is intended to treat diabetic macular edema, a condition that can cause blurred vision and blindness. The implant is designed to gradually release tiny amounts of a corticosteroid medication for three years. Alimera Sciences plans to launch the drug ...
Also read: Brexit Bulletin: A Clean Break
06:13 Pound quivers near three-month low, stocks weak before May's Brexit stance speech13
05:09 Sterling slides to 3-month lows on 'hard Brexit' fears12
01:03 Sterling slides to three-month lows on 'hard Brexit' fears11
22:15 Sterling skids on Brexit anxiety; investors hope for Donald Trump clarity13